Percheron Therapeutics Limited
Biotechnology Research • 
Melbourne, Victoria, Australia • 1-10 Employees
Company overview
| Headquarters | L30, 35 Collins Street, Melbourne, Victoria 3000, AU |
| Phone number | +611398278999 |
| Website | |
| NAICS | 541714 |
| Founded | 2000 |
| Employees | 1-10 |
| Socials |
Key Contacts at Percheron Therapeutics Limited
James Garner
Chief Executive Officer & Managing Director
Charmaine Gittleson
Non Executive Board Director
Andrew Mckenzie
Clinical Development Director
Percheron Therapeutics Limited Email Formats
Percheron Therapeutics Limited uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@percherontx.com), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@percherontx.com | 60% |
{first name}.{last name} | john.doe@percherontx.com | 40% |
About Percheron Therapeutics Limited
Percheron Therapeutics Limited (ASX: PER) is an international biotechnology company focused on the development of novel therapies for rare diseases. The company’s lead program is ATL1102, an antisense oligonucleotide targeting the CD49d receptor. ATL1102 is currently the subject of an ongoing international phase IIb clinical trial for the treatment of non-ambulant patients with Duchenne Muscular Dystrophy (DMD), for which data is expected in 2H CY2024. The drug has previously reported promising results from an exploratory phase IIa study in the same population and has been awarded orphan drug designation (ODD) and rare pediatric disease designation (RPDD) by the US FDA. For more information, please contact info@PercheronTx.com.
Percheron Therapeutics Limited revenue & valuation
| Annual revenue | $23,539 |
| Revenue per employee | $3,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $75,324 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Percheron Therapeutics Limited has 5 employees across 5 departments.
Departments
Number of employees
Funding Data
Percheron Therapeutics Limited has never raised funding before.
Percheron Therapeutics Limited Tech Stack
Discover the technologies and tools that power Percheron Therapeutics Limited's digital infrastructure, from frameworks to analytics platforms.
Security
Form builders
Cookie compliance
JavaScript libraries
JavaScript libraries
Web servers
Programming languages
Security
Blogs
Editors
Analytics
Video players
United States
Italy
United Kingdom
Canada
Frequently asked questions
4.8
40,000 users
